These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30956173)

  • 21. An integrated network of microRNA and gene expression in ovarian cancer.
    Quitadamo A; Tian L; Hall B; Shi X
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S5. PubMed ID: 25860109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis.
    Ho KH; Chen PH; Hsi E; Shih CM; Chang WC; Cheng CH; Lin CW; Chen KC
    Sci Rep; 2017 Apr; 7(1):732. PubMed ID: 28389653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated analysis of the miRNA-mRNA next-generation sequencing data for finding their associations in different cancer types.
    Bhowmick SS; Bhattacharjee D; Rato L
    Comput Biol Chem; 2020 Feb; 84():107152. PubMed ID: 31785969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRactDB characterizes miRNA-gene relation switch between normal and cancer tissues across pan-cancer.
    Tan H; Kim P; Sun P; Zhou X
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32436932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the NCI-60 dataset for cancer-related microRNA and mRNA using expression profiles.
    Weng CW; Lee SC; Lee YL; Ng KL
    Comput Biol Chem; 2013 Jun; 44():15-21. PubMed ID: 23499870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.
    Lee E; Ito K; Zhao Y; Schadt EE; Irie HY; Zhu J
    Bioinformatics; 2016 Jan; 32(1):96-105. PubMed ID: 26358730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated microRNA and proteome analysis of cancer datasets with MoPC.
    Lovino M; Ficarra E; Martignetti L
    PLoS One; 2024; 19(3):e0289699. PubMed ID: 38512819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying miRNA-mRNA regulatory relationships in breast cancer with invariant causal prediction.
    Pham VV; Zhang J; Liu L; Truong B; Xu T; Nguyen TT; Li J; Le TD
    BMC Bioinformatics; 2019 Mar; 20(1):143. PubMed ID: 30876399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer.
    Yang C; Sun C; Liang X; Xie S; Huang J; Li D
    Cancer Gene Ther; 2016 Apr; 23(4):90-7. PubMed ID: 26964645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
    Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
    Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
    Wilk G; Braun R
    Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OMCD: OncomiR Cancer Database.
    Sarver AL; Sarver AE; Yuan C; Subramanian S
    BMC Cancer; 2018 Dec; 18(1):1223. PubMed ID: 30522456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying cancer-related microRNAs based on gene expression data.
    Zhao XM; Liu KQ; Zhu G; He F; Duval B; Richer JM; Huang DS; Jiang CJ; Hao JK; Chen L
    Bioinformatics; 2015 Apr; 31(8):1226-34. PubMed ID: 25505085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery.
    Lin Y; Wu W; Sun Z; Shen L; Shen B
    RNA Biol; 2018; 15(8):1093-1105. PubMed ID: 30081733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis.
    Suzuki HI; Young RA; Sharp PA
    Cell; 2017 Mar; 168(6):1000-1014.e15. PubMed ID: 28283057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cross-cancer differential co-expression network reveals microRNA-regulated oncogenic functional modules.
    Lin CC; Mitra R; Cheng F; Zhao Z
    Mol Biosyst; 2015 Dec; 11(12):3244-52. PubMed ID: 26448606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential roles of microRNAs and their target genes in human multiple myeloma.
    Yang Y; Lin J; Ma Z; Li J; Li D; Wang B; Fei Q
    Eur J Haematol; 2017 Aug; 99(2):178-185. PubMed ID: 28467652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
    Kim SY; Kawaguchi T; Yan L; Young J; Qi Q; Takabe K
    Ann Surg Oncol; 2017 Oct; 24(10):2943-2949. PubMed ID: 28766230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.